The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AAC HLDGS INC | COM | 000307108 | 17,211 | 1,733,276 | SH | SOLE | 1,733,276 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | NOTE 3.250% 6/0 | 00163UAD8 | 15,747 | 16,250,000 | PRN | SOLE | 16,250,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 22,952 | 615,000 | SH | SOLE | 615,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 40,726 | 1,577,927 | SH | SOLE | 1,577,927 | 0 | 0 | ||
AEGERION PHARMACEUTICALS INC | NOTE 2.000% 8/1 | 00767EAB8 | 13,359 | 16,600,000 | PRN | SOLE | 16,600,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 30,749 | 632,686 | SH | SOLE | 632,686 | 0 | 0 | ||
ADVANCED ACCELERATOR APPLIC | SPONSORED ADS | 00790T100 | 14,741 | 218,000 | SH | SOLE | 218,000 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 5,449 | 1,221,775 | SH | SOLE | 1,221,775 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 13,884 | 208,000 | SH | SOLE | 208,000 | 0 | 0 | ||
AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 2,662 | 433,551 | SH | SOLE | 433,551 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 8,171 | 6,052,935 | SH | SOLE | 6,052,935 | 0 | 0 | ||
ALLSCRIPTS HEALTHCARE SOLUTN | NOTE 1.250% 7/0 | 01988PAD0 | 10,297 | 9,671,000 | PRN | SOLE | 9,671,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 10,824 | 933,100 | SH | SOLE | 933,100 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 28,811 | 824,338 | SH | SOLE | 824,338 | 0 | 0 | ||
ARALEZ PHARMACEUTICALS INC | COM | 03852X100 | 3,766 | 1,644,583 | SH | SOLE | 1,644,583 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 15,380 | 2,746,480 | SH | SOLE | 2,746,480 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 27,344 | 1,072,329 | SH | SOLE | 1,072,329 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 11,509 | 509,022 | SH | SOLE | 509,022 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 30,813 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 42,727 | 1,525,410 | SH | SOLE | 1,525,410 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 38,383 | 3,655,494 | SH | SOLE | 3,655,494 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 149,679 | 1,547,386 | SH | SOLE | 1,547,386 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 6,665 | 344,428 | SH | SOLE | 344,428 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W104 | 7,238 | 1,052,000 | SH | SOLE | 1,052,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 26,071 | 4,975,451 | SH | SOLE | 4,975,451 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 6,168 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
BIOSCRIP INC | COM | 09069N108 | 3,045 | 1,107,166 | SH | SOLE | 1,107,166 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 14,143 | 203,000 | SH | SOLE | 203,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 9,871 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
CLEMENTIA PHARMACEUTICALS IN | COM | 185575107 | 7,810 | 462,387 | SH | SOLE | 462,387 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 13,751 | 756,822 | SH | SOLE | 756,822 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 27,836 | 655,897 | SH | SOLE | 655,897 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 6,172 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 69,469 | 1,419,911 | SH | SOLE | 1,419,911 | 0 | 0 | ||
EDITAS MEDICINE INC | COM | 28106W103 | 41,043 | 1,709,400 | SH | SOLE | 1,709,400 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 16,078 | 672,994 | SH | SOLE | 672,994 | 0 | 0 | ||
ENDOLOGIX INC | NOTE 3.250%11/0 | 29266SAB2 | 35,030 | 40,500,000 | PRN | SOLE | 40,500,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 13,345 | 700,526 | SH | SOLE | 700,526 | 0 | 0 | ||
FLUIDIGM CORP DEL | NOTE 2.750% 2/0 | 34385PAA6 | 20,260 | 27,715,000 | PRN | SOLE | 27,715,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 4,537 | 817,435 | SH | SOLE | 817,435 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 13,228 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 83,392 | 2,527,032 | SH | SOLE | 2,527,032 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 36,813 | 362,724 | SH | SOLE | 362,724 | 0 | 0 | ||
HORIZON PHARMA INVT LTD | NOTE 2.500% 3/1 | 44052TAB7 | 66,895 | 74,100,000 | PRN | SOLE | 74,100,000 | 0 | 0 | ||
HORIZON PHARMA PLC | SHS | G4617B105 | 87,708 | 6,917,070 | SH | SOLE | 6,917,070 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 8,136 | 582,000 | SH | SOLE | 582,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 27,375 | 497,000 | SH | SOLE | 497,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 39,674 | 51,000,000 | PRN | SOLE | 51,000,000 | 0 | 0 | ||
INTERSECT ENT INC | COM | 46071F103 | 37,692 | 1,210,000 | SH | SOLE | 1,210,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 1,864 | 118,116 | SH | SOLE | 118,116 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 8,433 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
INVUITY INC | COM NEW | 46187J205 | 10,477 | 1,177,229 | SH | SOLE | 1,177,229 | 0 | 0 | ||
ISIS PHARMACEUTICALS INC DEL | NOTE 1.000%11/1 | 464337AJ3 | 48,504 | 45,700,000 | PRN | SOLE | 45,700,000 | 0 | 0 | ||
K2M GROUP HLDGS INC | NOTE 4.125% 8/1 | 48273JAB3 | 24,498 | 20,000,000 | PRN | SOLE | 20,000,000 | 0 | 0 | ||
KEMPHARM INC | NOTE 5.500% 2/0 | 488445AB3 | 45,688 | 75,000,000 | PRN | SOLE | 75,000,000 | 0 | 0 | ||
LANNET INC | COM | 516012101 | 26,813 | 1,453,259 | SH | SOLE | 1,453,259 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 15,568 | 169,000 | SH | SOLE | 169,000 | 0 | 0 | ||
MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 69,513 | 1,860,137 | SH | SOLE | 1,860,137 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 7,954 | 1,355,000 | SH | SOLE | 1,355,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 111,982 | 729,000 | SH | SOLE | 729,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 6,636 | 43,200 | SH | Call | SOLE | 43,200 | 0 | 0 | |
MIMEDX GROUP INC | COM | 602496101 | 1,782 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MOLINA HEALTHCARE INC | COM | 60855R100 | 17,740 | 258,000 | SH | SOLE | 258,000 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 98,929 | 3,153,611 | SH | SOLE | 3,153,611 | 0 | 0 | ||
MYOKARDIA INC | COM | 62857M105 | 58,492 | 1,365,039 | SH | SOLE | 1,365,039 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 6,199 | 400,685 | SH | SOLE | 400,685 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 28,120 | 2,181,542 | SH | SOLE | 2,181,542 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 14,356 | 1,568,921 | SH | SOLE | 1,568,921 | 0 | 0 | ||
NEVRO CORP | NOTE 1.750% 6/0 | 64157FAA1 | 32,756 | 27,600,000 | PRN | SOLE | 27,600,000 | 0 | 0 | ||
NUCANA PLC | SPONSORED ADR | 67022C106 | 7,806 | 424,950 | SH | SOLE | 424,950 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 43,588 | 1,579,285 | SH | SOLE | 1,579,285 | 0 | 0 | ||
OBALON THERAPEUTICS INC | COM | 67424L100 | 3,348 | 351,284 | SH | SOLE | 351,284 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 15,888 | 945,710 | SH | SOLE | 945,710 | 0 | 0 | ||
PATTERSON COMPANIES INC | COM | 703395103 | 21,876 | 566,000 | SH | SOLE | 566,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 16,130 | 298,545 | SH | SOLE | 298,545 | 0 | 0 | ||
PROTEON THERAPEUTICS INC | COM | 74371L109 | 2,450 | 1,224,899 | SH | SOLE | 1,224,899 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 1,491 | 102,150 | SH | SOLE | 102,150 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 5,909 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 17,077 | 1,901,685 | SH | SOLE | 1,901,685 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 4,236 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 9,795 | 653,000 | SH | SOLE | 653,000 | 0 | 0 | ||
SELECT MED HLDGS CORP | COM | 81619Q105 | 22,936 | 1,194,609 | SH | SOLE | 1,194,609 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 17,367 | 951,629 | SH | SOLE | 951,629 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM | 82640U107 | 4,340 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
STEADYMED LTD | SHS | M84920103 | 4,753 | 1,418,787 | SH | SOLE | 1,418,787 | 0 | 0 | ||
SYNLOGIC INC | COM | 87166L100 | 16,165 | 850,143 | SH | SOLE | 850,143 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 18,679 | 1,268,945 | SH | SOLE | 1,268,945 | 0 | 0 | ||
TRINITY BIOTECH INVT LTD | NOTE 4.000% 4/0 | 89643QAB4 | 38,190 | 48,000,000 | PRN | SOLE | 48,000,000 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 2,422 | 117,647 | SH | SOLE | 117,647 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 12,615 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 11,964 | 522,000 | SH | SOLE | 522,000 | 0 | 0 |